Enhancing Human Milk Production With Domperidone in Mothers of Preterm Infants: Results From the EMPOWER Trial

摘要

Background: Mothers of preterm infants often are at risk of expressing an inadequate amount of milk for their infants and the use of galactogogues is often considered. Domperidone is a widely used galactogogue with little information available to guide clinicians regarding initiation, timing, and duration of treatment.